Medical-device maker Biomet halted its plans for a public offering to instead agree to be purchased by Zimmer, another medical-products maker. Biomet, known for its artificial hips and knees, was taken private in 2007 by four leading private-equity sponsors. Zimmer is paying $13.3 billion for the majority of Biomet. PE firms bought Biomet in 2007 for $11 billion. Health-care merger activity remains vibrant. This time, PE firms found a strategic – rather than financial – buyer.
Subscribe to TheStreetTV on YouTube:
For more content from TheStreet visit:
Check out all our videos:
Follow TheStreet on Twitter:
Like TheStreet on Facebook:
Follow TheStreet on LinkedIn:
Follow TheStreet on Google+:
source
